Andropause: To treat or not to treat?

Journal of Endocrinological Investigation

Volumn 26, Issue 7, 2003, Pages 693-697

  Basaria, S ^a,b   Dobs, A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Andropause; Body composition; Frailty; Osteoporosis; Quality of life

Indexed keywords

ANDROGEN; ANDROSTANOLONE; CALCIUM CARBONATE; CHOLESTEROL; CHORIONIC GONADOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SILDENAFIL; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; TRIACYLGLYCEROL; VITAMIN D;

AGING; ANDROPAUSE; BODY COMPOSITION; BONE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MONITORING; DRUG SAFETY; FRACTURE; GYNECOMASTIA; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOCHOLESTEROLEMIA; HYPOGONADISM; LIBIDO; LIBIDO DISORDER; LONG TERM CARE; MALE; MUSCLE STRENGTH; PATIENT EDUCATION; POLYCYTHEMIA; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SCROTUM; SEXUAL FUNCTION; SLEEP APNEA SYNDROME; TRANSDERMAL PATCH;

EID: 0142088905     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347033     Document Type: Review

References (24)

1. Basaria S., Dobs A.S. Hypogonadism and androgen replacement therapy in elderly men. Am. J. Med. 2001, 110: 563-572.
2. Vermeulen A. Andropause. Maturitas. 2000, 34: 5-15.
3. Tenover J.S. Effects of testosterone supplementation in the aging male. J. Clin. Endocrinol. Metab. 1992, 75: 1092-1098.
4. Morley J.E., Perry H.M. 3rd, Kaiser F.E., et al. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study. J. Am. Geriatr. Soc. 1993, 41: 149-152.
5. Snyder P.J., Peachey H., Hannoush P., et al. Effect of testosterone treatment on bone mineral density in men over 65 yr of age. J. Clin. Endocrinol. Metab. 1999, 84: 1966-1972.
6. Snyder P.J., Peachey H., Hannoush P., et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 yr of age. J. Clin. Endocrinol. Metab. 1999, 84: 2647-2653.
7. Marin P., Holmang S., Jonsson L., et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int. J. Obes. Relat. Metab. Disord. 1992, 16: 991-997.
8. Sih R., Morley J.E., Kaiser F.E., Perry H.M. 3rd, Patrick P., Ross C. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J. Clin. Endocrinol. Metab. 1997, 82: 1661-1667.
9. Urban R.J., Bodenburg Y.H., Gilkison C., et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J. Physiol. 1995, 269: E820-E826.
10. Ly L.P., Jimenez M., Zhuang T.N., Celermajer D.S., Conway A.J., Handelsman D.J. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J. Clin. Endocrinol. Metab. 2001, 86: 4078-4088.
11. Liu P.Y., Wishart S.M., Handelsman D.J. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J. Clin. Endocrinol. Metab. 2002, 87: 3125-3135.
12. Ferrando A.A., Sheffield-Moore M., Yeckel C.W. et al. Testosterone administration to older men improves muscle function: Molecular and physiological mechanisms. Am J. Physiol. Endocrinol. Metab. 2002, 282: E601-607.
13. Korenman S.G., Morley J.E., Mooradian A.D., et al. Secondary hypogonadism in older men: Its relation to impotence. J. Clin. Endocrinol. Metab. 1990, 71: 963-969.
14. Schiavi R.C., Schreiner-Engel P., White D., Mandeli J. The relationship between pituitary-gonadal function and sexual behavior in healthy aging men. Psychosom. Med. 1991, 53: 363-374.
15. O'Carroll R., Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in men: A controlled study. Br. J. Psychiatry 1984,145: 146-151.
16. Hajjar R.R., Kaiser F.E., Morley J.E. Outcomes of long-term testosterone replacement in older hypogonadal males: A retrospective analysis. J. Clin. Endocrinol. Metab. 1997, 82: 3793-3796.
17. Barrett-Connor E., Von Muhlen D.G., Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 1999, 84: 573-577.
18. Moffatt S.D., Zonderman AB., Metter E.J., Blackman M.R., Harman S.M., Resnick S.M. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J. Clin. Endocrinol. Metab. 2002, 87: 5001-5007.
19. Janowsky J.S., Oviatt S.K., Orwoll E.S. Testosterone influences spatial cognition in older men. Behav. Neurosci. 1994, 108: 325-332.
20. Cherrier M.M., Asthana S., Plymate S., et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001, 57: 80-88.
21. Hayes F.J. Testosterone-fountain of youth or drug of abuse? J. Clin. Endocrinol. Metab. 2000, 85: 3020-3023.
22. Matsumoto A.M., Sandblom R.E., Schoene R.B., et al. Testosterone replacement in hypogonadal men: Effects on obstructive sleep apnoea, respiratory drives, and sleep. Clin. Endocrinol. (Oxf.) 1985, 22: 713-721.
23. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group J.A.M.A. 1998, 280: 605-613.
24. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. J.A.M.A. 2002, 288: 321-333.